Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes | Nature Communications
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases | Nature Reviews Immunology
Functional Modulation of Regulatory T Cells by IL-2 | PLOS ONE
Combined treatment with low dose IL-2 cplxs, rapamycin, and anti-IL-6... | Download Scientific Diagram
Mechanisms of action of low-dose IL-2 restoration therapies in SLE - ScienceDirect
JCI Insight - Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases | Nature Reviews Immunology
Ultra-low Dose Interleukin-2 Promotes Immune-modulating Function of Regulatory T Cells and Natural Killer Cells in Healthy Volunteers: Molecular Therapy
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus | Nature Medicine
Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives | SpringerLink
Effects of low-dose IL-2 on T regs and T cons in vivo. ( A )... | Download Scientific Diagram
Low-dose IL-2 therapy compensates for metabolic shifts and reverses anxiety-like behavior in PD-1 deficiency-induced autoimmunity | Cellular & Molecular Immunology
Sustained low‐dose interleukin‐2 therapy alleviates pathogenic humoral immunity via elevating the Tfr/Tfh ratio in lupus - Liang - 2021 - Clinical & Translational Immunology - Wiley Online Library
LOW DOSE IL-2 FOR THE TREATMENT OF MODERATE TO SEVERE ULCERATIVE COLITIS - Gastroenterology
Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus | PLOS Pathogens
Emerging mechanisms and applications of low-dose IL-2 therapy in autoimmunity - ScienceDirect
Low-dose IL-2 induces activation phenotype in the Treg subset at a... | Download Scientific Diagram
Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus | PLOS Pathogens
Frontiers | Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease | Science Translational Medicine
Effect of daily low-dose IL-2 therapy on each major lymphocyte... | Download Scientific Diagram
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial | Annals of the Rheumatic Diseases
Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis | SpringerLink
JCI Insight - Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells
Frontiers | Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
